Oracle Corporation $ORCL Shares Sold by Wealth Alliance LLC

Wealth Alliance LLC lowered its position in Oracle Corporation (NYSE:ORCLFree Report) by 38.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,188 shares of the enterprise software provider’s stock after selling 7,031 shares during the period. Wealth Alliance LLC’s holdings in Oracle were worth $2,446,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of ORCL. Lockheed Martin Investment Management Co. lifted its holdings in Oracle by 4.3% in the 1st quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider’s stock valued at $7,179,000 after purchasing an additional 2,110 shares in the last quarter. Private Wealth Asset Management LLC raised its position in shares of Oracle by 9.2% in the second quarter. Private Wealth Asset Management LLC now owns 3,817 shares of the enterprise software provider’s stock valued at $835,000 after buying an additional 321 shares during the last quarter. Soltis Investment Advisors LLC lifted its stake in shares of Oracle by 4.8% in the second quarter. Soltis Investment Advisors LLC now owns 32,937 shares of the enterprise software provider’s stock worth $7,201,000 after buying an additional 1,515 shares in the last quarter. Cascade Investment Group Inc. acquired a new position in Oracle during the second quarter worth about $239,000. Finally, Lockerman Financial Group Inc. acquired a new position in Oracle during the second quarter worth about $328,000. 42.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ORCL. Robert W. Baird assumed coverage on shares of Oracle in a research note on Wednesday, October 8th. They issued an “outperform” rating and a $365.00 target price on the stock. Piper Sandler increased their price target on Oracle from $330.00 to $380.00 and gave the company an “overweight” rating in a report on Friday, October 17th. William Blair reissued an “outperform” rating on shares of Oracle in a research note on Friday, October 17th. Mizuho upped their target price on Oracle from $300.00 to $350.00 and gave the company an “outperform” rating in a report on Wednesday, September 10th. Finally, Guggenheim lifted their price target on Oracle from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $323.69.

Read Our Latest Report on Oracle

Insider Activity at Oracle

In other news, CEO Clayton M. Magouyrk sold 40,000 shares of the firm’s stock in a transaction on Tuesday, October 21st. The stock was sold at an average price of $276.64, for a total transaction of $11,065,600.00. Following the completion of the transaction, the chief executive officer directly owned 154,030 shares in the company, valued at $42,610,859.20. This trade represents a 20.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Michael D. Sicilia sold 33,845 shares of the business’s stock in a transaction on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total value of $10,869,660.20. Following the completion of the sale, the insider owned 132,656 shares in the company, valued at $42,603,800.96. This represents a 20.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 204,254 shares of company stock valued at $60,227,807 over the last ninety days. 40.90% of the stock is owned by insiders.

Oracle Stock Down 2.0%

Shares of ORCL opened at $235.95 on Wednesday. The company’s 50-day moving average price is $279.83 and its 200 day moving average price is $232.71. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33. The firm has a market cap of $672.64 billion, a P/E ratio of 54.62, a price-to-earnings-growth ratio of 2.96 and a beta of 1.51.

Oracle (NYSE:ORCLGet Free Report) last announced its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). The company had revenue of $14.93 billion for the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period last year, the business earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts forecast that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th were given a $0.50 dividend. The ex-dividend date of this dividend was Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.8%. Oracle’s payout ratio is presently 46.30%.

Oracle Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Further Reading

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.